Bio-Techne (TECH) EPS (Basic) Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.50% |
| Dec 31, 2025 | -27.52% |
| Sep 30, 2025 | -22.07% |
| Jun 30, 2025 | -15.68% |
| Mar 31, 2025 | -31.82% |
| Dec 31, 2024 | -41.20% |
| Sep 30, 2024 | -11.18% |
| Jun 30, 2024 | -9.57% |
| Mar 31, 2024 | -23.46% |
| Dec 31, 2023 | -18.05% |
| Sep 30, 2023 | -7.00% |
| Jun 30, 2023 | -15.48% |
| Mar 31, 2023 | -3.22% |
| Dec 31, 2022 | -24.45% |
| Sep 30, 2022 | 6.30% |
| Jun 30, 2022 | -12.02% |
| Mar 31, 2022 | -7.95% |
| Dec 31, 2021 | 20.59% |
| Sep 30, 2021 | 28.40% |
| Jun 30, 2021 | -39.99% |
| Mar 31, 2021 | 7.82% |
| Dec 31, 2020 | 11.38% |
| Sep 30, 2020 | 7.36% |
| Jun 30, 2020 | 17.08% |
| Mar 31, 2020 | 7.89% |
| Dec 31, 2019 | 28.31% |
| Sep 30, 2019 | -10.18% |
| Jun 30, 2019 | -10.04% |
| Mar 31, 2019 | 6.53% |
| Dec 31, 2018 | -7.52% |
| Sep 30, 2018 | -9.07% |
| Jun 30, 2018 | 6.92% |
| Mar 31, 2018 | -10.05% |
| Dec 31, 2017 | 13.51% |
| Sep 30, 2017 | -9.71% |
| Jun 30, 2017 | 0.00% |
| Mar 31, 2017 | -7.26% |
| Dec 31, 2016 | -22.16% |
| Sep 30, 2016 | -7.17% |
| Jun 30, 2016 | -2.17% |
| Mar 31, 2016 | -0.72% |
| Dec 31, 2015 | -0.56% |
| Sep 30, 2015 | -2.99% |
| Jun 30, 2015 | 0.00% |
| Mar 31, 2015 | -5.66% |
| Dec 31, 2014 | 6.40% |
| Sep 30, 2014 | -2.02% |